Report Overview

Middle East and Africa Veterinary Vaccines Market – Industry Trends & Forecast Report, 2030

Middle East and Africa Veterinary Vaccines Market size was estimated at USD 472.06 million in 2023. During the forecast period between 2024 and 2029, the size of Middle East and Africa Veterinary Vaccines Market is projected to grow at a CAGR of 5.42% reaching a value of USD 648.06 million by 2030. The Middle East and Africa Veterinary Vaccines Market is propelled by rising awareness about animal health, increasing livestock population, and the prevalence of infectious diseases. Growing demand for protein-rich food products and the need to enhance agricultural productivity contribute to the market's expansion. Governments’ initiatives to control and prevent animal diseases, coupled with advancements in biotechnology, further drive vaccine adoption. Additionally, a surge in companion animal ownership and the emergence of zoonotic diseases underscore the importance of veterinary vaccines, fostering the growth of Middle East and Africa Veterinary Vaccines Market.

Veterinary Vaccines – Overview

Veterinary vaccines play a crucial role in safeguarding the health of animals by preventing and controlling infectious diseases. These vaccines stimulate the immune system to recognize and combat specific pathogens, reducing the severity of illnesses and minimizing transmission. Common vaccines target diseases like rabies, distemper, and brucellosis in various animal species. Advancements in vaccine technology, including recombinant DNA techniques, have improved efficacy and safety. Regular vaccination programs are integral to maintaining animal well-being, preventing economic losses in agriculture, and mitigating zoonotic risks, ultimately contributing to a healthier and more sustainable coexistence between humans and animals.

Middle East and Africa Veterinary Vaccines Market

Growth Drivers

Unprecedented Surge in Animal Diseases

Amidst the escalating prevalence of animal diseases in the Middle East and Africa, the veterinary vaccines market witnesses a remarkable upswing. As the region grapples with emerging health challenges affecting livestock and pets, the demand for advanced and effective vaccines intensifies. The surge in awareness and preventive measures is driving substantial growth in the Middle East and Africa Veterinary Vaccines Market, fostering a resilient ecosystem to combat the rising threat of animal diseases.

Challenges

Lack of Awareness about Benefits of Vaccination

In the dynamic landscape of the Middle East and Africa Veterinary Vaccines Market, the impediment of insufficient awareness about the advantages of vaccination emerges as a significant growth restraint for the market. The obstacle underscores the crucial need for comprehensive educational initiatives and advocacy campaigns to enlighten stakeholders about the pivotal role vaccinations play in ensuring the health and well-being of animals in the region.

Impact of Escalating Geopolitical Tensions on Middle East and Africa Veterinary Vaccines Market

The escalating geopolitical tensions in the Middle East and Africa have added a layer of uncertainty and volatility to the Veterinary Vaccines market, further compounded by Israel-Hamas conflict and Russia-Ukraine conflict. Economic sanctions and geopolitical challenges have created ripple effects across industries, influencing consumer sentiment and purchasing behaviors. In the context of recent tensions between Israel and its neighbors, various industries face potential revenue impacts. However, the Israeli government's strong focus on national security, including biosecurity, highlights the crucial role of the veterinary vaccines sector. Despite broader economic challenges, the sector remains essential for preserving animal populations, ensuring food security, and preventing bioterrorism. In navigating these complex dynamics, businesses must adopt agile and responsive veterinary vaccine strategies to address evolving consumer preferences and geopolitical landscapes.

Middle East and Africa Veterinary Vaccines Market

Segmental Coverage

Middle East and Africa Veterinary Vaccines Market – By Type

Based on type, Middle East and Africa Veterinary Vaccines Market is divided into Poultry Vaccine, Livestock Vaccines (Bovine Vaccines and Small Ruminant Vaccines), Companion Animal Vaccines (Feline Vaccines and Canine Vaccines), and Aquaculture Vaccine segments. The livestock vaccines segment, encompassing bovine vaccines and small ruminant vaccines segment is the largest in the Middle East and Africa Veterinary Vaccines Market. The sector plays a pivotal role in safeguarding the health of cattle and small ruminants, contributing significantly to the overall veterinary vaccine market in the region. With a focus on livestock health and welfare, these vaccines address the unique needs of bovine and small ruminant populations, reflecting the importance of the agricultural and farming sectors in the Middle East and Africa.

Middle East and Africa Veterinary Vaccines Market – By Technology

By technology, Middle East and Africa Veterinary Vaccines Market is divided into Live Attenuated Vaccines, Inactivated Vaccines (Toxoid Vaccines and Recombinant Vaccines), and Conjugate Vaccines segments. The inactivated vaccines segment, further categorized into toxoid vaccines and recombinant vaccines segments dominates the market share. The segment involves vaccines that are either deactivated or genetically engineered, offering a wide range of applications in veterinary medicine. Inactivated vaccines are crucial in preventing diseases among animals, and the toxoid and recombinant subcategories highlight the advanced technologies employed for heightened efficacy. The segment's prominence underscores the region's emphasis on innovative veterinary healthcare solutions, contributing significantly to the overall market landscape.

Middle East and Africa Veterinary Vaccines Market – By Disease

Based on disease, Middle East and Africa Veterinary Vaccines Market is divided into Porcine Disease, Poultry Disease, Livestock Disease, and Companion Animal Disease segments. The livestock disease segment stands out as the largest, indicating a significant focus on addressing health challenges in livestock. This emphasizes the importance of veterinary vaccines in ensuring the well-being of livestock populations in the Middle East and Africa region.

Middle East and Africa Veterinary Vaccines Market – By Distribution Channel

By distribution channel, Middle East and Africa Veterinary Vaccines Market is divided into Oral Vaccines, Injection Vaccines, and Intranasal Spray Vaccines segments. The injection vaccines segment reflects a significant preference for injectable formulations in veterinary vaccine administration. The dominance underscores the importance of injectable vaccines in the region's veterinary healthcare, possibly due to their efficacy and ease of administration, contributing substantially to the overall market share.

Middle East and Africa Veterinary Vaccines Market – By Country

Based on country, Middle East and Africa Veterinary Vaccines Market is divided into Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, and Rest of MEA. South Africa emerges as the largest, showcasing significant demand and market share for veterinary vaccines. The country's robust agricultural sector and growing awareness about animal health contribute to the dominance of South Africa in the regional veterinary vaccines market, making it a pivotal player in the industry's landscape.

Competitive Landscape

Major players in the Middle East and Africa Veterinary Vaccines Market include BIOVAC, Boehringer Ingelheim International GmbH, Ceva, Elanco, Hester Biosciences Limited, Merck & Co., Inc., NEOGEN Corporation, Virbac, and Zoetis Inc. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Middle East and Africa Veterinary Vaccines Market.

Recent Developments

• In July 2023: Kansas State University's College of Veterinary Medicine established the new Center on Vaccine Evaluation and Alternatives for Antimicrobials (CVEAA) to promote animal vaccine development and use.

Scope of Report

By Type

• Poultry Vaccine

1. Livestock Vaccines

• Bovine Vaccines

• Small Ruminant Vaccines

2. Companion Animal Vaccines

• Feline Vaccines

• Canine Vaccines

3. Aquaculture Vaccine

By Technology

• Live Attenuated Vaccines

• Inactivated Vaccines

• Toxoid Vaccines

• Recombinant Vaccines

• Conjugate Vaccines

By Disease

• Porcine Disease

• Poultry Disease

• Livestock Disease

• Companion Animal Disease

By Distribution Channel

• Oral Vaccines

• Injection Vaccines

• Intranasal Spray Vaccines

By Country

• Saudi Arabia

• UAE

• Qatar

• Kuwait

• South Africa

• Nigeria

• Algeria

• Rest of MEA

1. Research Framework
   1. Research Objective
   2. Technology Overview
   3. Market Segmentation
2. Executive Summary
3.  Middle East and Africa Veterinary Vaccines Market Insights
   1. Industry Value Chain Analysis
   2. DROC Analysis
      1. Growth Drivers
      2. Growth Drivers
         1. Rising prevalence of animal diseases
         2. Growing awareness of animal welfare
      3. Restraints
         1. High cost of vaccines
         2. Lack of awareness of vaccination benefits
      4. Opportunities
         1. Increasing demand for organic and sustainable livestock production
         2. Development of new vaccines
      5.  Challenges
         1. Availability of counterfeit vaccines
         2. Lack of cold chain infrastructure
   3. Technological Advancements/Recent Developments
   4. Regulatory Framework
   5. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
4.  Middle East and Africa Veterinary Vaccines Market Overview
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share and Forecast
      1. By Type
         1. Poultry Vaccine
         2. Livestock Vaccines
            1. Bovine Vaccines
            2.  Small Ruminant Vaccines
         3. Companion Animal Vaccines
            1. Feline Vaccines
            2. Canine Vaccines
            3. Others
         4. Aquaculture Vaccine
         5. Others
      2. By Technology
         1. Live Attenuated Vaccines
         2. Inactivated Vaccines
         3.  Toxoid Vaccines
         4.  Recombinant Vaccines
         5. Conjugate Vaccines
         6. Others
      3. By Disease
         1. Porcine Disease
         2. Poultry Disease
         3. Livestock Disease
         4. Companion Animal Disease
         5. Others
      4.  By Distribution Channel
         1. Oral Vaccines
         2. Injection Vaccines
         3. Intranasal Spray Vaccines
      5. By Country
         1. Saudi Arabia
         2. UAE
         3. Qatar
         4. Kuwait
         5. South Africa
         6. Nigeria
         7. Algeria
         8. Rest of MEA
5. Saudi Arabia Veterinary Vaccines Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Technology
      3. By Disease
      4. By Distribution Channel
6. UAE Veterinary Vaccines Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Technology
      3. By Disease
      4. By Distribution Channel
7. Qatar Veterinary Vaccines Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Technology
      3. By Disease
      4. By Distribution Channel
8. Kuwait Veterinary Vaccines Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Technology
      3. By Disease
      4. By Distribution Channel
9. South Africa Veterinary Vaccines Market
   1. Market Size & Forecast, 2019–2030
      1. By Value (USD Million)
   2. Market Share & Forecast
      1. By Type
      2. By Technology
      3. By Disease
      4. By Distribution Channel
10. Nigeria Veterinary Vaccines Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Million)
    2. Market Share & Forecast
       1. By Type
       2. By Technology
       3. By Disease
       4. By Distribution Channel
11. Algeria Veterinary Vaccines Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Million)
    2. Market Share & Forecast
       1. By Type
       2. By Technology
       3. By Disease
       4. By Distribution Channel
12. Rest of MEA Veterinary Vaccines Market
    1. Market Size & Forecast, 2019–2030
       1. By Value (USD Million)
    2. Market Share & Forecast
       1. By Type
       2. By Technology
       3. By Disease
       4. By Distribution Channel
13. Competitive Landscape
    1. List of Key Players and Their Offerings
    2. Middle East and Africa Veterinary Vaccines Market Share Analysis, 2023
    3. Competitive Benchmarking, By Operating Parameters
    4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
14. Impact of Escalating Geopolitical Tensions on Middle East and Africa Veterinary Vaccines Market
15. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
    1. BIOVAC
    2. Boehringer Ingelheim International GmbH
    3. Ceva
    4. Elanco
    5. Hester Biosciences Limited
    6. Merck & Co., Inc.
    7. NEOGEN Corporation
    8. Virbac
    9. Zoetis Inc.
    10. Other Prominent Players
16. Key Strategic Recommendations
17. Research Methodology
    1.    Qualitative Research
       1.  Primary & Secondary Research
    2.    Quantitative Research
    3.    Market Breakdown & Data Triangulation
       1.  Secondary Research
       2.  Primary Research
    4.    Breakdown of Primary Research Respondents, By Region
    5.    Assumptions & Limitations

*Financial information of non-listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable

List of Figures

Figure 1       Middle East and Africa Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030

Figure 2       Middle East and Africa Veterinary Vaccines Market Share, By Type, By Value, 2019–2030

Figure 3       Middle East and Africa Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030

Figure 4       Middle East and Africa Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030

Figure 5       Middle East and Africa Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030

Figure 6       Middle East and Africa Veterinary Vaccines Market Share, By Country, By Value, 2019–2030

Figure 7       Saudi Arabia Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030

Figure 8       Saudi Arabia Veterinary Vaccines Market Share, By Type, By Value, 2019–2030

Figure 9       Saudi Arabia Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030

Figure 10     Saudi Arabia Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030

Figure 11     Saudi Arabia Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030

Figure 12     UAE Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030

Figure 13     UAE Veterinary Vaccines Market Share, By Type, By Value, 2019–2030

Figure 14     UAE Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030

Figure 15     UAE Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030

Figure 16     UAE Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030

Figure 17     Qatar Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030

Figure 18     Qatar Veterinary Vaccines Market Share, By Type, By Value, 2019–2030

Figure 19     Qatar Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030

Figure 20     Qatar Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030

Figure 21     Qatar Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030

Figure 22     Kuwait Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030

Figure 23     Kuwait Veterinary Vaccines Market Share, By Type, By Value, 2019–2030

Figure 24     Kuwait Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030

Figure 25     Kuwait Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030

Figure 26     Kuwait Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030

Figure 27     South Africa Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030

Figure 28     South Africa Veterinary Vaccines Market Share, By Type, By Value, 2019–2030

Figure 29     South Africa Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030

Figure 30     South Africa Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030

Figure 31     South Africa Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030

Figure 32     Nigeria Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030

Figure 33     Nigeria Veterinary Vaccines Market Share, By Type, By Value, 2019–2030

Figure 34     Nigeria Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030

Figure 35     Nigeria Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030

Figure 36     Nigeria Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030

Figure 37     Algeria Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030

Figure 38     Algeria Veterinary Vaccines Market Share, By Type, By Value, 2019–2030

Figure 39     Algeria Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030

Figure 40     Algeria Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030

Figure 41     Algeria Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030

Figure 42     Rest of MEA Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030

Figure 43     Rest of MEA Veterinary Vaccines Market Share, By Type, By Value, 2019–2030

Figure 44     Rest of MEA Veterinary Vaccines Market Share, By Technology, By Value, 2019–2030

Figure 45     Rest of MEA Veterinary Vaccines Market Share, By Disease, By Value, 2019–2030

Figure 46     Rest of MEA Veterinary Vaccines Market Share, By Distribution Channel, By Value, 2019–2030

List of Tables

Table 1        Middle East and Africa Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030                    

Table 2        Middle East and Africa Veterinary Vaccines Market Size, By Type, By Value, 2019–2030                    

Table 3        Middle East and Africa Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030                    

Table 4        Middle East and Africa Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030                    

Table 5        Middle East and Africa Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030                   

Table 6        Middle East and Africa Veterinary Vaccines Market Size, By Country, By Value, 2019–2030                    

Table 7        Saudi Arabia Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030                            

Table 8       Saudi Arabia Veterinary Vaccines Market Size, By Type, By Value, 2019–2030                   

Table 9         Saudi Arabia Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030                    

Table 10      Saudi Arabia Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030                            

Table 11      Saudi Arabia Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030                    

Table 12      UAE Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030                        

Table 13      UAE Veterinary Vaccines Market Size, By Type, By Value, 2019–2030                      

Table 14      UAE Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030                     

Table 15      UAE Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030                          

Table 16      UAE Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030                    

Table 17      Qatar Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030                      

Table 18      Qatar Veterinary Vaccines Market Size, By Type, By Value, 2019–2030                    

Table 19      Qatar Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030                   

Table 20      Qatar Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030                        

Table 21      Qatar Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030                    

Table 22      Kuwait Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030                    

Table 23      Kuwait Veterinary Vaccines Market Size, By Type, By Value, 2019–2030                          

Table 24      Kuwait Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030                            

Table 25      Kuwait Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030                      

Table 26      Kuwait Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030                    

Table 27      South Africa Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030                            

Table 28      South Africa Veterinary Vaccines Market Size, By Type, By Value, 2019–2030                   

Table 29      South Africa Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030                            

Table 30      South Africa Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030                            

Table 31      South Africa Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030                    

Table 32      Nigeria Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030                   

Table 33      Nigeria Veterinary Vaccines Market Size, By Type, By Value, 2019–2030                          

Table 34      Nigeria Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030                            

Table 35      Nigeria Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030                      

Table 36      Nigeria Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030                    

Table 37      Algeria Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030                    

Table 38      Algeria Veterinary Vaccines Market Size, By Type, By Value, 2019–2030                          

Table 39      Algeria Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030                            

Table 40      Algeria Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030                      

Table 41      Algeria Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030                    

Table 42      Rest of MEA Veterinary Vaccines Market Size, By Value (USD Million), 2019–2030                            

Table 43      Rest of MEA Veterinary Vaccines Market Size, By Type, By Value, 2019–2030                   

Table 44      Rest of MEA Veterinary Vaccines Market Size, By Technology, By Value, 2019–2030                            

Table 45      Rest of MEA Veterinary Vaccines Market Size, By Disease, By Value, 2019–2030                            

Table 46      Rest of MEA Veterinary Vaccines Market Size, By Distribution Channel, By Value, 2019–2030                    

Table 47      BIOVAC Company Overview

Table 48      BIOVAC Financial Overview

Table 49      Boehringer Ingelheim International GmbH Company Overview

Table 50      Boehringer Ingelheim International GmbH Financial Overview

Table 51      Ceva Company Overview

Table 52      Ceva Financial Overview

Table 53      Elanco Company Overview

Table 54      Elanco Financial Overview

Table 55      Hester Biosciences Limited Company Overview

Table 56      Hester Biosciences Limited Financial Overview

Table 57      Merck & Co., Inc. Company Overview

Table 58      Merck & Co., Inc. Financial Overview

Table 59      NEOGEN Corporation Company Overview

Table 60      NEOGEN Corporation Financial Overview

Table 61      Virbac Company Overview

Table 62      Virbac Financial Overview

Table 63      Zoetis Inc. Company Overview

Table 64      Zoetis Inc. Financial Overview